Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis 2026-09-22
  2. Smartphone Passive Digital Phenotyping in Frontotemporal Lobar Degeneration 2026-09-21
  3. Diagnostic Value of Large Language Model-Extracted Gross Brain Findings in Neurodegenerative Diseases 2026-09-14

Studies

1,022 studies carry this tag.

Date range

1967 to 2026

Top journals

  • Neurology 106
  • Brain : a journal of neurology 71
  • Movement disorders : official journal of the Movement Disorder Society 53
  • Annals of neurology 34
  • The Lancet. Neurology 34

313 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Limbic-predominant age-related TDP-43 encephalopathy in the oldest old: a population-based study

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Brain 2025-01-07 Laboratory science

    Previous studies have shown that limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) increases with age, but there have been only a few studies, which have investigated this entity in a population-based setting.

  2. Positron emission tomography tracers for synucleinopathies

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Molecular Neurodegeneration 2025-01-05 Disease mechanisms

    Synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by the aggregation of α-synuclein.

  3. Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain Communications 2025-01-01 Lewy body dementia

    Lewy body patients showed a significantly higher degree of WMSA in the external capsule cholinergic pathway despite no significant differences in global WMSA compared to controls.

  4. Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2025-01-01 Lewy body dementia

    Plasma p‐tau217 has clinical, neuroimaging, and neuropathological correlates in sporadic FTD and may identify FTD cases with AD co‐pathology.

  5. Differentiating sporadic frontotemporal dementia from late-onset primary psychiatric disorders

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Brain Communications 2025-01-01 Lewy body dementia

    Higher scores in cognitive screening [odds ratio (OR): 1.23], facial emotion processing (OR: 1.69), episodic memory (OR: 1.09), animal fluency (OR: 1.17), working memory (OR: 1.18), letter fluency (OR: 1.17) and depressive symptoms (OR: 7.41) were significantly associated with PPD (all Ps ≤ 0.010).

  6. Executive dysfunction relates to salience network desegregation in behavioural variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. NeuroImage Clinical 2025-01-01 Lewy body dementia

    • Executive dysfunction is a key characteristic of bvFTD. • Network de-differentiation reflects loss of specialized networks. • De-differentiation of the salience network relates to executive dysfunction in bvFTD. • Reduced network capacity for specialized processing may mediate emergence of executive dysfunction.

  7. Frontotemporal dementia characterization using neurite orientation dispersion and density imaging

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Brain Communications 2025-01-01 Lewy body dementia

    Microstructural alterations in brain tissue play a crucial role in the pathophysiology of frontotemporal dementia (FTD).

  8. Multiplex connectomics reveal altered networks in frontotemporal dementia: A multisite study

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Network Neuroscience 2025-01-01 Lewy body dementia

    A network neuroscience perspective can significantly advance the understanding of neurodegenerative disorders, particularly frontotemporal dementia (FTD).

  9. Peripheral Single‐Cell Immune Characteristics Contribute to the Diagnosis of Alzheimer's Disease and Dementia With Lewy Bodies

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. CNS Neuroscience & Therapeutics 2025-01-01 Lewy body dementia

    These models demonstrated high diagnostic efficacy in distinguishing diseased samples from healthy donors as well as distinguishing AD and DLB cases.

  10. Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Brain Communications 2025-01-01 Lewy body dementia

    In the last few years, co-ultramicronized palmitoylethanolamide combined with luteoline has emerged as a potential therapeutic molecule in neurodegenerative disorders pathogenically related to frontotemporal dementia, for its demonstrated strong anti-inflammatory and neuroprotective properties.

  11. Quantitative electroencephalography in the diagnosis of dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Clinical Neurophysiology Practice 2025-01-01 Lewy body dementia

    The spectral analysis of the resting-state eyes-closed electroencephalographic (rsEEG) activity typically shows abnormal delta (< 4 Hz), theta (4-7 Hz), and alpha (8-12 Hz) power in older patients with cognitive deficits due to progressive neurodegenerative diseases.

  12. Significantly higher serum median NfL and GFAP levels were found in sporadic bvFTD (NfL 33.3 pg/mL, IQR (19.6-49.6); GFAP 124.5 pg/mL, IQR (83.5-181.6)) compared with PPD (NfL 12.2 pg/mL, IQR (9.8-17.9); GFAP 68.9 pg/mL, IQR (50.6-95.0), both p<0.001).

  13. Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2025-01-01 Lewy body dementia

    Sex differences for clinicopathological correlations in LBD also occur at the regional pathology level.

  14. Stable isotope labelling kinetics of neurofilament light

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Brain Communications 2025-01-01 Disease mechanisms

    These findings support the interpretation that acute rises in CSF NfL concentration are likely to be related to passive release or CSF clearance failure.

  15. Striatal dopaminergic patterns and clinical features in frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Brain Communications 2025-01-01 Lewy body dementia

    Moreover, a theoretical model proposes that frontotemporal dementia manifestations result from a deficit in goal-directed behaviour, which may be related to altered dopamine control of the frontostriatal circuitry.

  16. The causal association between resting state intrinsic functional networks and neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain Communications 2025-01-01 Genetics

    None of the genetically proxied functional network features were significantly associated with neurodegenerative outcomes (adjusted P value >0.05), despite sufficient calculated power.

  17. Greater neighborhood deprivation is related to shorter survival in behavioral‐variant frontotemporal degeneration

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Alzheimer s & Dementia 2024-12-01 Risk factors

    Our results suggest that increased neighborhood deprivation contributes to shorter survival in bvFTD.

  18. Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Nature Communications 2024-09-14 Laboratory science

    Identifying concomitant Lewy body (LB) pathology through seed amplification assays (SAA) might enhance the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice and trials.

  19. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Nature reviews. Molecular cell biology 2024-08-06 Brain tissue and pathology

    Autophagy is a lysosome-based degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and aggregate-prone proteins.

  20. An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Parkinsonism & Related Disorders 2024-05-28 Risk factors

    There were no between-group differences in traditional performance measures of motor, cognitive, or IADL function.

  21. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Nature communications 2024-03-29 Disparities

    The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites.

  22. Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain research 2024-03-21 Tau biomarkers

    We enrolled 69 individuals diagnosed with Lewy body dementia (LBD), comprising both dementia with Lewy bodies (DLB) (n = 36) and Parkinson's disease dementia (PDD) (n = 33).

  23. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Annals of neurology 2024-03-11 Digital health tools

    Clinical data alone poorly predicted phenoconversion in RBD due to synucleinopathy patients.

  24. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. The Lancet. Neurology 2024-02-01 Getting a diagnosis

    Parkinson's disease and dementia with Lewy bodies are currently defined by their clinical features, with α-synuclein pathology as the gold standard to establish the definitive diagnosis.

  25. Medical, surgical, and physical treatments for Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Lancet (London, England) 2024-01-01 Digital health tools

    Although dopamine replacement therapy remains a core component of Parkinson's disease treatment, the onset of motor fluctuations and dyskinetic movements might require a range of medical and surgical approaches from a multidisciplinary team, and important new approaches in the delivery of dopamine replacement are becoming available.

  26. Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. JAMA neurology 2024-01-01 Treatments

    At 6 months, compared with usual care, participants receiving the intervention had better QOL (QOL-AD score, 0.09 [95% CI, -0.63 to 0.82] vs -0.88 [95% CI, -1.62 to -0.13]; treatment effect estimate, 0.97; 95% CI, 0.07-1.86; P = .03).

  27. The epidemiology of Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Lancet (London, England) 2024-01-01 Prevention and risk

    The epidemiology of Parkinson's disease shows marked variations in time, geography, ethnicity, age, and sex.

  28. Speech and language markers of neurodegeneration: a call for global equity

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Brain : a journal of neurology 2023-12-01 Digital health tools

    In the field of neurodegeneration, speech and language assessments are useful for diagnosing aphasic syndromes and for characterizing other disorders.

  29. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Signal transduction and targeted therapy 2023-09-22 Lewy body dementia

    Microglia activation is observed in various neurodegenerative diseases.

  30. Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. Neurology 2023-07-27 Long-term cohort studies

    Choroid plexus (ChP) is emerging as a key brain structure in the pathophysiology of neurodegenerative disorders.

  31. Analysis of Japanese nationwide health datasets: association between lifestyle habits and prevalence of neuropathic pain and fibromyalgia with reference to dementia-related diseases and Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 30 out of 100. Scandinavian journal of pain 2023-07-13 Health systems and care delivery

    Chronic pain is defined as pain that persists or recurs for more than 3 months.

  32. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Brain : a journal of neurology 2023-06-01 Caregiving

    The presence of multiple additive pathologies associated with older age, increasing disease duration, APOE e4 allele and presence of dementia across the clinical groups.

  33. Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease

    ✓ Peer-reviewed alzhub usefulness score 65 out of 100. JAMA neurology 2023-05-01 Long-term cohort studies

    Cross-sectional evidence implicates high prevalent frailty in patients with Parkinson disease (PD), whereas the longitudinal association remains unknown.

  34. Motor and cognitive performance differed across PD and control groups.

  35. Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Cell death & disease 2023-03-01 Risk factors

    Although the discovery of the critical role of α-synuclein (α-syn) in the pathogenesis of Parkinson's disease (PD) is now twenty-five years old, it still represents a milestone in PD research.

  36. Classification and staging of Parkinson's disease using video-based eye tracking

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Parkinsonism & related disorders 2023-02-08 Digital health tools

    Biomarkers of saccade, pupil, and blink were extracted from video-based eye tracking to create a classifier with high sensitivity to the landscape of PD cognitive and motor dysfunction.

  37. Mediterranean diet is associated with a lower probability of prodromal Parkinson's disease and risk for Parkinson's disease/dementia with Lewy bodies: A longitudinal study

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. European journal of neurology 2023-02-06 Prevention trials

    Mediterranean diet adherence is associated with lower increase in pPD probability over time and lower possible/probable pPD and PD/DLB incidence in older Mediterranean people.

  38. Structures of α-synuclein filaments from human brains with Lewy pathology

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Nature 2022-09-15 Getting a diagnosis

    Parkinson's disease (PD) is the most common movement disorder, with resting tremor, rigidity, bradykinesia and postural instability being major symptoms 1 .

  39. Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Brain communications 2022-06-22 Tau biomarkers

    Among people with multiple sclerosis, cognitive impairment occurs commonly and is a potent predictor of disability.

  40. The Impact of Type 2 Diabetes in Parkinson's Disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Movement disorders : official journal of the Movement Disorder Society 2022-06-14 Mild cognitive impairment

    Because it is a potentially modifiable metabolic state, with multiple peripheral and central targets for intervention, it may represent a target for alleviating parkinsonian symptoms and slowing progression to disability and dementia. © 2022 The Authors.

  41. Imaging of Synaptic Density in Neurodegenerative Disorders

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2022-06-01 Disease mechanisms

    Next, we review human PET imaging results in multiple neurodegenerative disorders.

  42. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Brain : a journal of neurology 2022-06-01 Digital health tools

    Comparisons of ADNC in typical amnestic versus atypical aphasic dementia and of TDP in type A versus type C revealed fundamental biological and clinical differences, suggesting that members of each pair may constitute distinct clinicopathologic entities despite identical downstream proteinopathies.

  43. Epilepsy in neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Epileptic disorders : international epilepsy journal with videotape 2022-04-01 Down syndrome and Alzheimer's

    Although epilepsy as a comorbidity in neurodegenerative disorders is increasingly recognized, its incidence is still underestimated and the features of epilepsy in the different neurodegenerative conditions are still poorly defined.

  44. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Brain : a journal of neurology 2022-03-01 Mild cognitive impairment

    Significant progress has been made in understanding the pre-symptomatic phase of amyotrophic lateral sclerosis.

  45. Allostatic-Interoceptive Overload in Frontotemporal Dementia

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Biological psychiatry 2022-02-24 Digital health tools

    These results suggest that bvFTD may be characterized by an allostatic-interoceptive overload manifested in ongoing electrophysiological markers, brain atrophy, functional networks, and cognition.

  46. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study

    ✓ Peer-reviewed alzhub usefulness score 70 out of 100. Movement disorders : official journal of the Movement Disorder Society 2022-02-02 Cognitive tests and assessment

    Common genetic variance in apolipoprotein E (APOE), β-glucocerebrosidase (GBA), microtubule-associated protein tau (MAPT), and α-synuclein (SNCA) has been linked to cognitive decline in Parkinson's disease (PD), although studies have yielded mixed results.

  47. Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder

    ✓ Peer-reviewed alzhub usefulness score 58 out of 100. Annals of neurology 2022-01-24 Disparities

    Our findings elucidate the predictive values of environmental factors and comorbid conditions in identifying RBD patients at higher risk of phenoconversion.

  48. Lewy body disease or diseases with Lewy bodies?

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. NPJ Parkinson's disease 2022-01-10 Disease mechanisms

    The current nosological concept of α-synucleinopathies characterized by the presence of Lewy bodies (LBs) includes Parkinson's disease (PD), Parkinson's disease dementia (PDD), and dementia with Lewy bodies (DLB), for which the term "Lewy body disease" (LBD) has recently been proposed due to their considerable clinical and pathological overlap.

  49. Acute peri-operative neurocognitive disorders: a narrative review

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Anaesthesia 2022-01-01 Clinical safety

    Peri-operative neurocognitive disorders are the most common complication experienced by older individuals undergoing anaesthesia and surgery.

  50. Possible association between PM2.5 and neurodegenerative diseases: A systematic review

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Environmental research 2021-12-31 Inflammation and the immune system

    Air pollution is one of the most serious environmental problems that afflict our planet and one of the greatest risk factors for human health.

From across this tag

10 of the 1,021 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts